Cardinal Health PT Raised to $51.00 at Mizuho (CAH)
A number of other analysts have also recently weighed in on CAH. Analysts at Raymond James reiterated an outperform rating on shares of Cardinal Health in a research note to investors on Tuesday, February 12th. They now have a $50.00 price target on the stock. Separately, analysts at Zacks reiterated a neutral rating on shares of Cardinal Health in a research note to investors on Monday, February 11th. They now have a $47.00 price target on the stock. Finally, analysts at ISI Group raised their price target on shares of Cardinal Health from $50.00 to $50.50 in a research note to investors on Tuesday, February 5th. They now have a strong-buy rating on the stock.
Ten analysts have rated the stock with a buy rating, three have assigned an overweight rating, and three have issued a hold rating to the company. Cardinal Health presently has a consensus rating of overweight and a consensus price target of $50.41.
Shares of Cardinal Health opened at 46.28 on Thursday. Cardinal Health has a one year low of $36.91 and a one year high of $46.87. The stock’s 50-day moving average is currently $45.34. The company has a market cap of $15.775 billion and a P/E ratio of 14.05.
The company also recently announced a quarterly dividend, which is scheduled for Monday, April 15th. Shareholders of record on Monday, April 1st will be paid a dividend of $0.28 per share. This represents a $1.10 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Wednesday, March 27th.
Cardinal Health, Inc. (Cardinal Health) is a global healthcare solutions company providing products and services to hospitals, physician offices and pharmacies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.